1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsClinical Trials Grants Program (for Orphan Products) is sponsored by Food and Drug Administration (FDA). The FDA's Office of Orphan Products Development (OOPD) administers this program, awarding clinical trial grants for orphan products.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Orphan Products Grants Program | FDA Skip to in this section menu Medical products for rare diseases and conditions Grant Programs to Support Development of Medical Products for Rare Diseases Orphan Products Grants Program Grant Programs to Support Development of Medical Products for Rare Diseases The FDA Office of Orphan Product Development (OOPD) administers several grant programs that provide incentives to promote and accelerate the development of innovative products for the treatment, prevention and diagnosis of rare diseases .
Orphan Products Grants Program The Orphan Drug Act (ODA) enacted by Congress in 1983 provides incentives to defray the costs of developing drugs, biologics, devices, and medical foods for rare diseases or conditions.
The Orphan Products Grants Program awards grants to clinical investigators to support the development of safe and effective medical products (drugs, biologics, medical devices, and foods for medical purposes) for patients with rare diseases or conditions. Rare diseases are statutorily defined as those affecting fewer than 200,000 persons in the United States.
Although there are over 7,000 rare diseases that affect more than 30 million Americans, prior to the incentives established by the ODA, there was little market interest in developing medical products for rare diseases. Clinical Trials Grants Program - Funds clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions (since 1983).
Learn more and view grants awarded . Natural History Studies Grants Program - Funds well-designed, protocol-driven natural history studies that address knowledge gaps, support clinical trials, and advance rare disease medical product development (since 2016). Learn more and view grants awarded .
Additional Rare Disease Grants OOPD also administers the FDA Rare Neurodegenerative Disease Grants Program . Established by the ACT for ALS Act in 2021, this program awards grants and contracts to cover the costs of research and development of interventions intended to prevent, diagnose, or treat amyotrophic lateral disease (ALS) and other rare neurodegenerative diseases in adults and children (since 2022).
Resources for Applicants and Grantees FAQs for Orphan Products Grant Applicants Technical Support and OOPD Grants Contacts
According to the current listing, eligibility includes: Any foreign or domestic, public or private, for-profit or nonprofit entity (including state and local units of government). Federal agencies may not apply. Confirm the full requirements in the official notice before applying.
Clinical Trials Grants Program (for Orphan Products) is funded by Food and Drug Administration (FDA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The AFID Infrastructure Grant program closes October 30, 2026. Awards top out at $50,000, they are reimbursable, and only a political subdivision can apply. The August round put $507,000 into 14 projects at an average of about $36,000.
Read articleThe Cold Chain Grants for Emergency Food Assistance Program closes October 1, 2026, funding cold storage equipment at up to $200,000 per project with a 10% cash match. But USDA is not awarding to food banks — it is awarding to nonprofit intermediaries who will run competitive subaward programs. Two audiences, two entirely different jobs, and one of them has 43 days.
Read articleMissouri's Department of Agriculture has reopened its Urban Agriculture Cost-Share Grant — reimbursing 75% of project costs up to $10,000, with applications due September 15, 2026. A companion Food Insecure Cost-Share Grant closes August 26. Here is how these small, fast state grants work, who qualifies under the Census 'urban area' definition, and how to layer them with the federal USDA Urban Agriculture and Innovative Production program for a durable urban-farming funding strategy.
Read article